NCT00561379
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Nantes University Hospital Nantes, France
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,977 public trials
2,028 recruiting studies
Immunoproliferative Disorders trial results
Completed
Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies
NCT00048737
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT01271127
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +16 more
- Locations
-
- Leiden University Medical Center Leiden, South Holland, Netherlands
NCT00002700
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Algemeen Ziekenhuis Middelheim Antwerp, Belgium
- A.Z. St. Jan Bruges, Belgium
- C.H.U. Saint-Pierre Brussels, Belgium
- Hopital Universitaire Erasme Brussels, Belgium
NCT00613665
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Duodenal Diseases, +20 more
- Locations
-
- Universitaetsklinikum Charité Berlin, Germany
NCT00868413
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- Site Reference ID/Investigator# 17841 La Jolla, California, United States
- Site Reference ID/Investigator# 25899 Stanford, California, United States
- Site Reference ID/Investigator# 21622 Baltimore, Maryland, United States
- Site Reference ID/Investigator# 21621 Columbus, Ohio, United States
NCT01230983
- Conditions
- Cardiac Toxicity, Cardiotoxicity, Cardiovascular Diseases, +17 more
- Locations
-
Not specified
NCT00010192
- Conditions
- B-cell Adult Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +82 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00077467
- Conditions
- Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, Bone Marrow Diseases, +24 more
- Locations
-
- COG Phase I Consortium Arcadia, California, United States
Completed
Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas
NCT00101270
- Conditions
- Astrocytoma, Burkitt Lymphoma, Childhood Burkitt Lymphoma, +115 more
- Locations
-
- COG Phase I Consortium Arcadia, California, United States